#Shingles Vaccine Market Share

[industryforecastnews]

Shingles Vaccine Market Size To Reach USD 11.26 Billion By 2030

Shingles Vaccine Market Growth & Trends

The global shingles vaccine market size is expected to reach USD 11.26 billion by 2030, registering a CAGR of 15.34% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of shingles and high awareness regarding shingles in developed countries are contributing to the market growth. According to the CDC, nearly one million cases of shingles are reported each year in the United States. Furthermore, one out of three individuals in the country will develop the disease in their lifetime.

The increasing adoption of vaccines and an increase in the recommendation of vaccination by different government regulatory bodies are expected to drive the market over the forecast period. For instance, in February 2019, the U.K. Joint Committee of Vaccination and Immunization (JCVI) has recommended the use of the recombinant vaccine to prevent shingles in adults aged 60 to 70 years old.

The inclusion of shingles vaccines in national immunization programs of several countries is anticipated to propel the demand for vaccines. For instance, the shingles vaccine is a part of the national immunization program in the U.K. since 2013. The U.K. is the first country in the European region to introduce shingles vaccine in the national immunization program and it costs around USD 130 to the National Health Service (NHS) for each dose of the vaccine. Similarly, other countries such as the U.S., Italy, Australia, and some provinces of Canada and South Korea have also included the vaccine in their immunization program.

Besides, favorable initiatives undertaken by market players and regulatory bodies to increase the awareness among people who are at risk of developing the disease are expected to fuel the market growth over the coming years. For instance, GlaxoSmithKline plc. has launched a campaign to increase vaccination rates among older adults by educating people about the benefits associated with vaccination.

The high efficacy of vaccines is expected to increase the adoption over the forecast period. According to clinical trial results, Shingrix is highly efficient to prevent shingles and postherpetic neuralgia. Two doses of Shingrix are more than 90% effective to prevent the disease in adults aged 50 years and above. Protection stays above 85% for at least the first four years after getting vaccinated.

The availability of vaccines at lower prices, coupled with a high incidence of the disease and high vaccination rate in developed countries, is anticipated to fuel the market growth. The vaccination rate against shingles in the U.K., the U.S., France, Canada, Germany, and South Korea is higher compared to other countries owing to better reimbursement policies and high awareness levels regarding the disease and vaccines. For instance, the U.K. has the highest shingles vaccine uptake with more than 60% vaccination of eligible adults.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/shingles-vaccine-market-report

Shingles Vaccine Market Report Highlights

By product, Shingrix held the largest share in 2023, owing to the high efficacy of the vaccine as compared to others. Shingrix is also expected to grow at a significant CAGR over the forecast period owing to the increasing recommendations by regulatory bodies to prevent shingles

Based on vaccine type, the recombinant vaccine segment is anticipated to grow at a substantial rate over the forecast period due to the low risk associated with recombinant vaccines

Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and the rising adoption of vaccination programs in the region

North America dominated the market in 2023, due to favorable reimbursement policies and rising initiatives to raise awareness among healthcare professionals and patients.

Shingles Vaccine Market Segmentation

Grand View Research has segmented the global shingles vaccine market based on product, type, end-use, and region:

Shingles Vaccine Product Outlook (Revenue, USD Million, 2018 - 2030)

Shingrix

Zostavax

SKYZoster

Shingles Vaccine Type Outlook (Revenue, USD Million, 2018 - 2030)

Recombinant Vaccine

Live Attenuated Vaccine

Shingles Vaccine End Use Outlook (Revenue, USD Million, 2018 - 2030)

Private Healthcare Settings

Government Healthcare Settings

Shingles Vaccine Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

Kuwait

UAE

List of Key Players of Shingles Vaccine Market

GlaxoSmithKline plc.

Merck & Co., Inc.

SK chemicals

Green Cross Corp

Geneone Life Science

Vaccitech

CanSinoBIO

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/shingles-vaccine-market-report

[bishtmeenakshi]

Vaccinating the World: Can the Market Deliver on Its Promise?

Explore the potential of the vaccine market to deliver on its promise of global immunization. Analyze trends, size, and future outlook across various vaccine segments, including pneumococcal, dengue, DNA, typhoid fever, and foot and mouth disease vaccines market.

[mitalipingale]

The Shingles Vaccine Market in 2023 is US$ 3.99 billion, and is expected to reach US$ 8.63 billion by 2031 at a CAGR of 10.10%.

[heathcareforallworld]

Growth in the Shingles Treatments Market

The shingles treatments market is a critical component of the global healthcare landscape, driven by the increasing prevalence of shingles, also known as herpes zoster, and the growing awareness of its complications. Shingles is a viral infection caused by the varicella-zoster virus, the same virus responsible for chickenpox. After a person recovers from chickenpox, the virus can remain dormant in nerve tissues and reactivate later in life, leading to shingles. This painful condition primarily affects older adults and individuals with weakened immune systems, making it a significant public health concern. This article delves into the current market size and share of shingles treatments, explores key industry trends, and provides insights into the factors shaping the market.

Market Size and Share

Shingles treatments Market Size was estimated at 3.01 (USD Billion) in 2023. The Shingles Treatments Market Industry is expected to grow from 3.13(USD Billion) in 2024 to 4.2 (USD Billion) by 2032. The shingles treatments Market CAGR (growth rate) is expected to be around 3.76% during the forecast period (2024 - 2032).This growth is primarily driven by the increasing incidence of shingles, an aging global population, and the rising awareness of the importance of early treatment and vaccination.

North America currently dominates the shingles treatments market, accounting for nearly 45% of the global market share. The high prevalence of shingles in the region, coupled with the availability of advanced healthcare facilities and widespread awareness, has contributed to this dominance. Europe follows closely, with a significant market share driven by similar factors. The Asia-Pacific region is anticipated to experience the fastest growth, attributed to increasing healthcare expenditure, rising awareness, and a growing aging population.

Industry Trends

Rising Prevalence of Shingles: The increasing incidence of shingles is one of the primary drivers of the market. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 3 people in the United States will develop shingles in their lifetime, with around 1 million cases diagnosed each year. The risk of developing shingles increases with age, particularly in individuals over 50. This growing prevalence underscores the need for effective treatment options, driving the demand for antiviral medications, pain management therapies, and vaccines.

Advancements in Antiviral Therapies: Antiviral medications are the cornerstone of shingles treatment, helping to reduce the severity and duration of the illness. The market has seen significant advancements in antiviral therapies, with newer drugs offering improved efficacy and fewer side effects. Commonly used antiviral drugs include acyclovir, valacyclovir, and famciclovir, which are effective in reducing the replication of the varicella-zoster virus. Ongoing research and development in this area are expected to lead to the introduction of more potent and convenient antiviral options.

Increased Focus on Vaccination: Vaccination is a crucial preventive measure against shingles, particularly for older adults. The introduction of vaccines such as Zostavax and Shingrix has significantly impacted the shingles treatment market. Shingrix, in particular, has gained widespread acceptance due to its high efficacy rate of over 90% in preventing shingles and its complications, including postherpetic neuralgia (PHN). The growing emphasis on vaccination, driven by public health campaigns and recommendations from healthcare authorities, is expected to boost the market for shingles vaccines.

Growing Awareness of Complications: Shingles can lead to serious complications, the most common of which is postherpetic neuralgia (PHN), a condition characterized by persistent nerve pain that can last for months or even years after the rash has healed. The increasing awareness of these complications is driving the demand for comprehensive treatment options that address both the acute phase of the illness and its long-term effects. This includes the use of pain management therapies, such as analgesics, corticosteroids, and nerve blocks, in addition to antiviral medications.

Development of Combination Therapies: The market is witnessing a growing interest in combination therapies that target multiple aspects of shingles treatment. For example, combining antiviral medications with pain management therapies or corticosteroids can help improve patient outcomes by addressing both the viral infection and the associated pain and inflammation. This trend towards combination therapies is expected to drive innovation and expand the range of treatment options available to patients.

Telemedicine and Remote Care: The COVID-19 pandemic has accelerated the adoption of telemedicine and remote healthcare services, a trend that is also impacting the shingles treatments market. Telemedicine allows healthcare providers to diagnose and manage shingles remotely, ensuring that patients receive timely treatment without the need for in-person visits. This approach is particularly beneficial for older adults and individuals with mobility issues, who may find it challenging to access traditional healthcare facilities.

Increasing R&D Investments: The shingles treatments market is witnessing increased investments in research and development, with pharmaceutical companies focusing on developing new and improved therapies. This includes the exploration of novel antiviral agents, vaccines, and pain management solutions. The growing pipeline of potential treatments, coupled with ongoing clinical trials, is expected to contribute to the market's expansion in the coming years.

Focus on Pain Management: Managing the pain associated with shingles, particularly PHN, is a critical aspect of treatment. The market is seeing a growing emphasis on developing effective pain management therapies, including topical analgesics, anticonvulsants, antidepressants, and nerve blocks. These treatments aim to alleviate the severe and often debilitating pain that can accompany shingles, improving the quality of life for affected individuals.

Awareness and Education Campaigns: Public health organizations and healthcare providers are increasingly focusing on awareness and education campaigns to inform the public about shingles, its risks, and the importance of early treatment and vaccination. These campaigns are crucial in encouraging older adults to seek preventive care and timely treatment, thereby driving the demand for shingles-related healthcare services.

Regional Disparities in Access to Treatment: While the market is growing globally, there are significant regional disparities in access to shingles treatment and vaccination. In high-income countries, access to antiviral medications and vaccines is widespread, while in low- and middle-income countries, access may be limited due to cost and availability. Addressing these disparities is essential for ensuring equitable access to shingles treatments worldwide.

Aging Population and Healthcare Needs: The global population is aging, with the number of people aged 60 and over expected to reach 2.1 billion by 2050. This demographic shift is driving the demand for healthcare services, including shingles treatments, as older adults are more susceptible to the virus. The increasing healthcare needs of this population are expected to be a significant driver of market growth over the next decade.

Conclusion

The shingles treatments market is poised for substantial growth over the next decade, driven by the rising prevalence of shingles, advancements in antiviral therapies, and the increasing focus on vaccination and pain management. As the global population ages and awareness of the complications associated with shingles grows, the demand for effective treatment options is expected to increase. With ongoing research and development, the market is likely to see the introduction of new and improved therapies, further expanding the range of options available to patients.

[omkarpatel]

Adult Vaccines Market is Estimated to Witness High Growth Owing to Opportunity of Reduction in Disease Burden

Adult vaccines are primarily used in immunizing adults against diseases such as hepatitis, influenza, pneumonia and herpes zoster. These vaccines help protect individuals against severe illnesses and reduce the disease burden. Adult vaccines are usually prescribed for individuals above 18 years of age or for those entering adulthood. They are important in reducing risks of vaccine preventable diseases and controlling epidemic outbreaks. The global Adult Vaccines Market is estimated to be valued at US$ 16,790.11 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The opportunity for reduction in disease burden is expected to drive significant growth of the adult vaccines market. Preventing diseases through vaccination can significantly reduce illness, disability and mortality among adults. Widespread adult vaccination programs can substantially lower the burden of many vaccine-preventable diseases globally. For instance, vaccination against influenza and pneumonia is crucial to protect adults from severe complications arising from these conditions. These vaccines can prove beneficial in reducing hospitalization, medical costs and loss of productivity associated with such diseases. Similarly, vaccination of adults against hepatitis B and herpes zoster significantly cuts down the risk of chronic liver disease and painful complications of shingles later in life. Effective vaccination coverage in older adults thus presents a major market opportunity to lower disease prevalence rates. This in turn is projected to augment demand for adult vaccines over the forecast period. Porter's Analysis Threat of new entrants: Low- Medium. Significant capital is required to conduct R&D and bring new vaccines to market. Regulatory barriers also exist. Bargaining power of buyers: Medium. A large customer base of healthcare providers and govts who purchase vaccines. Market consolidated with few major players. Bargaining power of suppliers: Low. Major pharma companies control intellectual property and production. Suppliers have less influence on prices. Threat of new substitutes: Low. Limited substitute prevention measures compared to effectiveness of vaccines. Competitive rivalry: High. Major players compete on innovation, pricing and market share. SWOT Analysis Strengths: Growing aging population worldwide increases market. Vaccines save on long term healthcare costs. Weaknesses: Low awareness in developing nations. Vaccine hesitancy and refusals impact uptake rates. Opportunities: Development of immunotherapies and combo vaccines presents scope. Untapped potential in certain countries. Threats: Stringent regulations delay products. Outbreaks can impact demand prognosis. Vaccine price control policies hurt revenue. Key Takeaways The global Adult Vaccines market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to grow from US$ 16,790.11 Mn in 2023 to US$ 33,678.42 Mn by 2030 at a CAGR of 7.1%. Key players operating in the adult vaccines market are GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc. Major players are focused on expanding their portfolio through acquisitions and new product launches.

[1-2-3-4-4498-0]

Solar Energy and Health: The Vaccine Refrigeration Revolution

Solar-powered vaccine refrigerator Market are designed to store vaccines and other medical products at a stable temperature to ensure they do not degrade. In developing countries with a sunny climate, solar-powered vaccine refrigerators are common. Many vaccines must be stored at low temperatures, some below -15 °C, and others between 2 and 8 °C. If vaccines are not stored correctly, they can lose their effectiveness.

The ideal temperature for storing vaccines in the ILR is +2 degrees to + 8 degrees According to the Centre for Disease Control, failure to adhere to recommended specifications for storage and handling of immunobiology’s can reduce or destroy their potency, resulting in inadequate or no immune response in the recipient. Maintenance of vaccine quality is the shared responsibility of all handlers of vaccines from the time a vaccine is manufactured until administration. According to the Immunization Action Coalition, all vaccines should be stored in a refrigerator or freezer that is designed specifically for the storage of biologics or, alternatively, in a separate dedicated unit. 

A dorm-style combination refrigerator-freezer unit with just one exterior door has been shown to be unacceptable no matter where the vaccine was placed inside the unit. Stand-alone refrigerator or freezer units are best for storage needs. With retail pharmacies now playing a major role in pneumonia, influenza and shingles immunization programs, the value of critical vaccines being stored in pharmacy refrigerators has reached a new high. In fact, it is not uncommon for many pharmacies to now have over $100,000 of product in a single refrigerator during peak seasons.

COVID-19 Impact analysis

The COVID pandemic, and now finally, the vaccination push across the world against the disease has put the spotlight firmly on the role distributed solar products, particularly Solar refrigeration could play

Rockwell Industries Ltd, a commercial cold chain appliances manufacture, Thursday launched its new product called ‘Chillermill’ here. The product is both a freezer and chiller useful to store COVID-19 vaccine at the required temperatures.

The Vaccine Alliance — began buying and installing solar-powered fridges to store vaccines throughout the region. The idea would be a gamechanger for regional and district health workers who often struggle to carry out routine immunizations for children in places with unreliable electricity and cold storage facilities.

Top Impacting Factors

Solar refrigeration was an encouraging development in the early 1980s, providing a substitute for the absorption technology to meet cold chain requirements in remote areas with finite or no electric power. At present, various solar refrigeration models prequalified by the World Health Organization (WHO) are in use. A fresh approach in solar-based refrigeration has emerged, wherein the newly designed solar refrigerator has gotten rid of the need for high priced energy storage batteries employed to power solar refrigerators. This technology called solar direct drive technology uses solar energy to directly freeze water or other cold storage material (for instance, refrigerant) and then, uses the energy stored in the frozen bank to keep the refrigerator cold during nights and rainy days when the upcoming solar energy is not within easy reach.

Market Trends

Solar-powered vaccine refrigerators, also called off-grid photovoltaic (PV) systems, are put to use to maintain a continues temperature suitable for storing vaccines in clinics

In solar-powered vaccine refrigerators, photovoltaic modules transmute the solar energy directly into electricity, which is further employed to power the compressor of the vaccine refrigerator. On the other hand, rechargeable batteries are also used to store electric energy. The charge controller regulates the flow of electricity to protect batteries from over-discharging and overcharging.

Use of solar-based refrigeration for vaccine storage is a major development in the global health care industry. It is useful for remote areas, where electricity is not available in sufficient amounts. The global health care industry has witnessed rapid growth in the recent years. Growing elderly population worldwide, high prevalence of chronic diseases, and advancements in innovative digital technologies are some of the major factors driving the global health care industry.

Electricity rates are inherently turbulent. They fluctuate seasonally, monthly, and annually. Over the last decade, electricity prices had increased enormously and they are poised to increase even more during the forecast period. This, in turn, is projected to rise the demand for use of the solar technology for storage of vaccines in the near future.

There exists high demand for exploration of sustainable and clean sources for energy, as the world tries to limit emissions and targets to reach net zero carbon emissions

Government support in the form of favorable initiatives has driven usage of the solar technology over the last few years. This is estimated to be a major factor driving the global solar-powered vaccine refrigerator market during the forecast period. For instance, the Solar Energy Corporation of India (SECI) has passed a tender, wherein the government would be offering 30% subsidy to the social sector, the residential sector, private and not-for-profit organizations in the field of education, and health care institutions.

Key Benefits of the Report

This study presents the analytical depiction of the Solar-powered vaccine refrigerator industry along with the current trends and future estimations to determine the imminent investment pockets.

The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Solar-powered vaccine refrigerator market share.

The current market is quantitatively analyzed from 2020 to 2030 to highlight the Solar-powered vaccine refrigerator market growth scenario.

Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.

The report provides a detailed Solar-powered vaccine refrigerator market analysis based on competitive intensity and how the competition will take shape in coming years.

Key Market Players : ACMAS Technologies (P) Ltd KYOCERA Corporation, QINGDAO HERALD CRYOGENIC TECHNOLOGY CO., LTD, Godrej Appliances,, Qingdao Amed Commercial Refrigeration Equipment Co., Ltd, RuthurEnergy Limited, Meditech Technologies India Private Limited, Sure Chill, Haier, Vestfrost Solutions,, Neumann & Miller, Dulas Ltd., Renaissance Energy Systems, Sundanzer

[kenresearch2023]

GSK vs Sanofi - A Battle for Medical Breakthroughs and Global Healthcare Dominance: Ken Research

Global Pharmaceutical leaders GSK and Sanofi competing for market share in vaccines, general healthcare with investments in R&D and new collaborations.

Storyline

Sanofi, a global pharmaceutical company, has a strong market presence in therapeutic areas like diabetes, cardiovascular diseases, and vaccines. Sanofi Pasteur, its vaccines division, is a leading manufacturer worldwide.

GSK, a British multinational, excels in respiratory health, HIV, vaccines, and consumer healthcare. GSK Vaccines is renowned for its vaccine offerings.

Both companies heavily invest in R&D to innovate and develop new drugs and vaccines. Sanofi emphasizes partnerships, while GSK focuses on genetically identified and infectious disease targets.

Strategic collaborations drive their growth strategies. Sanofi partners with Regeneron Pharmaceuticals and has a premium partnership for the Paris 2024 Olympic and Paralympic Games. GSK collaborates with organizations like the University of California and IDEAYA in areas like oncology.

Introduction

Sanofi and GSK are both global pharmaceutical companies engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products.

1. Revenue and Market Presence:

Sanofi:

Sanofi is a French multinational pharmaceutical company with a significant global presence. It has a diverse portfolio of products across various therapeutic areas, including diabetes, cardiovascular diseases, vaccines, and rare diseases. Sanofi is one of the top pharmaceutical companies worldwide. It is headquartered in Paris, France. In 2022, influenza vaccines generated approximately three billion euros of revenue.

GSK:

GlaxoSmithKline, a British multinational pharmaceutical company, is also a major player in the global pharmaceutical industry. It operates in various segments such as pharmaceuticals, vaccines, and consumer healthcare. GSK has a strong presence in areas like respiratory health, HIV, vaccines, and consumer healthcare products.

Product Portfolio:

Sanofi:

Sanofi's product portfolio includes branded prescription drugs such as Lantus (insulin), Dupixent (for atopic dermatitis and asthma), and Aubagio (for multiple sclerosis). Sanofi also has a significant presence in the vaccine market, including vaccines for influenza, meningococcal diseases, and paediatric diseases.

GSK:

GSK's product portfolio encompasses prescription medicines like Advair (for respiratory diseases), Augmentin (antibiotic), and Tivicay (for HIV). GSK has a strong focus on vaccines, including those for hepatitis, shingles, and influenza. Additionally, it offers a wide range of consumer healthcare products, including Sensodyne, Panadol, and Voltaren.

Vaccine Market:

Both Sanofi and GSK have notable expertise and market presence in the vaccine segment. However, their focus and capabilities may vary.

Sanofi

To learn more about this report Download a Free Sample Report 

Sanofi is known for its vaccines division, Sanofi Pasteur, which develops vaccines for various diseases, including influenza, dengue, polio, and meningitis. Sanofi Pasteur is one of the largest vaccine manufacturers globally.

GSK

Visit this Link: – Request for custom report 

GSK has a substantial presence in vaccines as well. It produces vaccines for diseases such as hepatitis, shingles, rotavirus, and meningitis. GSK's vaccine division is called GSK Vaccines.

Research and Development (R&D):

Both Sanofi and GSK invest significantly in research and development activities to discover and develop new drugs and vaccines.

Sanofi

https://www.researchnewstoday.com/wp-content/uploads/2023/07/Clinical-Trials-in-Vietnam.png

Sanofi has multiple R&D centres globally, focusing on various therapeutic areas. It emphasizes partnerships and collaborations to enhance its R&D efforts. “We’ve identified conditions in immunology and inflammation as areas of great opportunity. The challenge of developing new treatments for conditions such as atopic dermatitis and asthma is just one of the many in which we believe AI can offer game-changing aid." said Generous-Marlin.

GSK

In 2022, GSK invested £5.5 Bn in R&D – 9% AER more than 2021 - to enhance GSK’s pipeline of vaccines and medicines and help us get ahead of disease together. GSK scientists prioritise genetically identified targets that are at least twice as likely to succeed in the clinic.  They also prioritise infectious disease targets and immune-modulators that have greater lifecycle opportunities.

Strategic Collaborations and Partnerships:

Both companies actively pursue strategic collaborations with other pharmaceutical firms, research institutions, and biotech companies to strengthen their pipelines and access new technologies. Sanofi has entered into various collaborations, such as its partnership with Regeneron Pharmaceuticals for the development of biologics, including Dupixent.

Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris.

"Sanofi is proud to contribute to the success of the Olympic and Paralympic Games Paris 2024. It represents a great opportunity to unite our employees around shared values with the Olympics and Paralympics, such as inclusion and diversity, openness to the world, courage, determination and excellence." Says Paul Hudson, Sanofi CEO. GSK has formed partnerships with multiple organizations, including the University of California, to explore novel therapies and approaches in areas like oncology and immunology.

IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology

It's important to note that the competitive landscape in the pharmaceutical industry can be dynamic, with mergers, acquisitions, and new product launches shaping the market.

According to Ken Research: Sanofi and GSK compete in various therapeutic areas, with diverse product portfolios and a focus on vaccines. They invest in R&D and form strategic collaborations to drive innovation. The dynamic nature of the pharmaceutical industry, characterized by mergers, acquisitions, and product launches, shapes their competitive landscape.

[foodpornzzi]

New Residential Projects In Andheri Market Is Booming At Terrific Speed

There was a time when the usage of the words, "Yoga" and "business," in the identical sentence, would have been considered "shameful." However, when you might have a Yoga studio, pay for a lease, promoting, insurance coverage, utilities, and extra - you know this is serious enterprise. Growing your individual Yoga enterprise can begin on a component time foundation and later grow to be full time, in the event you get the fitting steering and take the proper steps. This has been a radical job change for all of us, who go into teaching Yoga full time, however you don't must take any sudden or monetary dangers. The most effective Yoga teachers are those who can talk, and those teachers often should battle to excel at Yoga. If you're still a little bit confused as to what this boutiques near me is all about, it is best to think about what it's attempting to be. This is true in some cases; nonetheless, you possibly can shop round for one of the best course at essentially the most reasonably priced worth. However, there might properly be a number of causes for funding out there market. Also, established Yoga studio owners could wish to "recession proof" their enterprise or enhance their market share right now. The market may be on the move, however some strategists on wall st are saying this Trump rally is getting a little bit long within the tooth, and telling their members that stocks cannot keep going up in a straight line for months on end.

There are charitable belief took motion and bought stocks like Nvidia and Activision Blizzard on weakness. KESSELHEIM: I anticipate that, after the virus turns into extra like an endemic virus, hopefully by late 2021, on account of the vaccine and public health measures below the Biden administration, that the coronavirus vaccine will likely be obtainable much more like other vaccines, just like the influenza vaccine and pneumonia vaccine or shingles vaccine and change into part of the conventional market in which vaccines are offered for high prices by their manufacturers. Utilities like Fortis function in a heavily regulated environment and earn a particular rate of return. Right now, there are quite a lot of Yoga studios that "flounder" economically, because the homeowners have inadequate enterprise or advertising and marketing abilities. Whether you own a Yoga studio, or are an unbiased contractor, your money is "on the road," and presumably your life savings. As the popularity of Yoga grows, more Yoga teachers are in search of professional recommendation to "stream line," market successfully, and make their Yoga businesses "recession proof." For some Yoga teachers, Yoga has advanced from a sideline hobby to a fulltime Yoga business. If bacteria spreads it might probably lead to a response from your physique which makes the acne swollen, red, and more uncomfortable.

[reportsanddata]

Live Attenuated Vaccines Market Size, Company Revenue Share, Key Drivers & Trend Analysis, 2020–2028

A new research report titled global Live Attenuated Vaccines Market report published by Reports and Data provides a brief overview of the industry and gives an estimation of growth and revenue for the forecast period of 2021-2028. The report covers profiling and study of major manufacturers of the Live Attenuated Vaccines market along with their sales, revenue, and market share. The report further analyzes market segments, size, trends, growth drivers, restraining factors, opportunities and challenges, cost overview, SWOT analysis, and Porter’s Five Forces Analysis. The report all includes industrial chain analysis, revenue growth, sales estimation, value chain analysis, capacity, regional market examination, and market forecast up to 2028. The report offers insightful information that will assist in gaining a market position and maximize on lucrative growth opportunities.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4800

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

Merck & Co., Inc.

GlaxoSmithKline plc

Pfizer Inc.

Sanofi

Astellas Pharma,

CSL Limited

Serum Institute of India Pvt. Ltd.

BioDiem

AstraZeneca

Emergent BioSolutions Inc.

Vivaldi Biosciences Inc.

Excavators

The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4800

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Live Attenuated Vaccines market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the Live Attenuated Vaccines industry, the market is segmented into:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

Bacterial

Cholera vaccine

Typhoid oral vaccine

BCG (tuberculosis) vaccine

Viral

Oral polio vaccine (OPV)

Vaccinia (smallpox) vaccine

Adenovirus oral vaccine (military)

Yellow fever vaccine

Shingles vaccine

Varicella (chickenpox) vaccine

Influenza vaccine (nasal spray)

Flumist

Rotavirus vaccine

MMR vaccine.

End-use Outlook (Revenue, USD Billion; 2018-2028)

Hospital

Pharmacies and drug stores

The regional analysis covers:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

US.

Canada

Mexico

Germany

UK.

Italy

France

BENELUX

Rest of Europe

China

India

Japan

South Korea

Rest of APAC

Brazil

Rest of LATAM

Saudi Arabia

A.E.

South Africa

Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/live-attenuated-vaccines-market

Benefits of Live Attenuated Vaccines Market Report:

Panoramic overview of the opportunities and risks in the Live Attenuated Vaccines sector

Study of recent innovations and developments in the industry

Comprehensive study of the growth pattern of the Live Attenuated Vaccines industry

In-depth assessment of the competitive landscape of the key players of the Live Attenuated Vaccines industry

Analysis of the Live Attenuated Vaccines market drivers, constraints, and opportunities

Assessment of technological developments and latest trends of the industry

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4800 Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

Similar Research reports by Reports and Data of Pharma and Healthcare Industry:

Rehabilitation Robots Market Size, Share & Analysis by Type (Therapeutic, Exoskeleton, Assistive, and Others), By End Use (Hospitals, Rehabilitation Centers, Prosthetic Clinics, and Others), And By Region Forecast to 2028

Steam Autoclave Market By Product Type (Table Top Autoclaves, Vertical Steam Autoclaves, Horizontal Steam Autoclaves), By Application (Medical Steam Autoclaves, Dental Steam Autoclaves, and Laboratory Steam Autoclaves), By End-use (Hospitals & Clinics, Healthcare Companies), and By Region Forecast to 2028

Algae Supplements Market s, Beauty & Health Stores), By Application (Nutraceuticals & Dietary Supplements, Pharmaceuticals, Personal Care Products), and By Region Forecast to 2028

DNA Testing Machine Market , By Product Type (Small Scale DNA Testing Machine, Medium Scale DNA Testing Machine, Large Scale DNA Testing Machine), By End-use (Clinic, Hospital, Laboratory, Others), and By Region Forecast to 2028

About Reports and Data              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com LinkedIn | Twitter | Blogs

[jesse-pinkman123]

Lidocaine Patches Market Size Share Trends Forecast Opportunity Analysis 2026

Lidocaine Patches Market Dynamics

Increasing number generic approved product in the market are expected to augment the Lidocaine Patches Market growth. Patent expiry of Endo Pharmaceuticals for Lidoderm offers growth opportunity for market players to develop generic version of the lidocaine patch. For instance, in 2015, Mylan Pharmaceuticals, Inc., launched the generic version of Endo Pharmaceutical's Lidoderm in the U.S. market. In 2014, Galen US Incorporated receive FDA approval for Synera, lidocaine and tetracaine topical patch for domestic use. Moreover, companies are introducing advanced technologies in lidocaine patches in order to maintain leading position in market, For instance, in 2016, Gregory Pharmaceutical Holdings, Inc. launched Lidocare, which is first and only patch that is water-free. Lidocare is the new over-the-counter/non-prescription lidocaine pain patch and the technology is under the patenting process. In February 2018, Sorrento Therapeutics, Inc., a subsidiary of Scilex Pharmaceuticals Inc., received U.S. FDA approval for ZTlido 1.8%, with the company’s proprietary adhesion technology. Furthermore, companies are also conducting clinical trials for expanding the application of lidocaine patch for disease and conditions such as Endo Pharmaceuticals, Inc., is conducting clinical trial for the use of lidocaine patch in osteoarthritis, chronic lower back pains, Carpal Tunnel Syndrome etc.

Lidocaine is an aminoethylamide local and topical anesthetic medication, causing temporary numbness or loss of sensation in the area of application. Lidocaine blocks the voltage-gated sodium channels of nerve membranes, thereby preventing the generation and conduction of nerve impulses and providing analgesic relief.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1805

Lidocaine patch 5% comprises a soft, stretchy adhesive patch containing 5% lidocaine for the topical treatment of pain associated with Post Herpetic Neuralgia (PHN). The first FDA approved transdermal lidocaine patch was Lidoderm, in 1999, by Endo Pharmaceuticals Inc. Increasing incidence of back and neck pain is the key factors driving growth of the market. However, availability of alternatives for the pain management such as other pain killer drugs are expected to restrain growth of the lidocaine patches market growth.

Increasing incidence of the shingles is expected to fuel growth of the lidocaine patches market during the forecast period. Shingles, also known as herpes zoster, leads to the chronic pain known as Post Herpetic Neuralgia (PHN) in which lidocaine patches are used. According to Centers for Disease Control and Prevention (CDC), January 2018, an estimated one third of the total U.S. population develops shingles during their lifetime, which suggests nearly 1 million Americans experiences shingles infection annually. Furthermore, CDC estimated that around 10 to 15% people with shingles infection experience PHN.

Lidocaine Patches Market - Regional Analysis

Regional segmentation of lidocaine patches market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America lidocaine patches market holds dominant position, owing to large number of product launches by the regional players and strategic collaborations among market players to introduce their product in regional market. For instance, Galen’s acquisition of Synera patch, a product of Nuvo Research, to commercialize the product in U.S. lidocaine patches market. Furthermore, reimbursement policies in North America related to lidocaine patch are supporting the market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/lidocaine-patches-market-1805

Moreover, Asia Pacific Lidocaine Patches Market is expected to witness fast growth attributed to increasing incidence of herpes zoster in these region and lack of preventive vaccination against shingles, which is expected to boost the lidocaine patches market growth.

Lidocaine Patches Market - Competitive Analysis

This market is highly fragmented, with the presence of Mylan Pharmaceuticals Inc., Endo Pharmaceutical Inc., Teva Pharmaceutical, Inc., Teikoku Pharma USA, Hisamitsu Pharmaceuticals Co. Inc., Galen US Inc., Sorrento Therapeutics, Inc. and Actavis Labs UT Inc. market players.

Manufacturers are focused on acquisition of complementary companies to enter the market with advanced products in lidocaine patches. For instance, in 2013, Galen entered into a product acquisition and license agreement with Nuvo Research Inc. pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain. Acquisition offers exclusive rights to market and sell Nuvo's Synera patch throughout the U.S. for its current indication. Under these agreement Nuvo Research Inc. will receive royalties of 10% of net sales.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1805

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

[olko71]

New Post has been published on All about business online

New Post has been published on http://yaroreviews.info/2021/02/covid-19-vaccines-to-stress-test-grocery-stores-and-pharmacies

Covid-19 Vaccines to Stress-Test Grocery Stores and Pharmacies

Some of America’s biggest retailers are preparing to take a central role in administering Covid-19 shots, hoping to avoid logjams and other complications that have slowed the vaccine rollout’s early days.

The U.S. fell far short of its initial goal of inoculating 20 million people by the end of 2020, with health departments, hospital systems and long-term-care facilities beset by supply-chain bottlenecks, vaccine hesitancy and confusing, scattershot systems for making appointments.

Not all Americans are eligible for the vaccines, and shots remain in short supply. But vaccines are becoming more broadly available in some states, and the federal Centers for Disease Control and Prevention aims to make them available in local pharmacies beginning next month. There is no cost to receive the vaccine.

(Check the WSJ’s state-by-state guide.)

The job of vaccinating large swaths of the population will fall largely on retail pharmacies, with companies such as CVS Health Corp. CVS -0.27% , Walgreens WBA -2.83% -Boots Alliance Inc., Walmart Inc. WMT -0.87% and Kroger Co. KR -2.32% saying they are prepared to give tens of millions of shots a month.

“We’re going to have to look at ways to increase our access points. We’ve got to be able to step up the pace to vaccinate people across the country if we want to make a dent in this,” said Bart Buxton, co-chair of the Covid-19 vaccine taskforce for McLaren Health Care Corp. The Flint, Mich.-based hospital system teamed with Walgreens to administer doses to its 26,000 employees as part of the first phase of vaccinations.

Pharmacy chains like Walgreens have been working with hospitals and care facilities to administer Covid-19 vaccines to staff and residents.

Photo: Jeff Lautenberger for The Wall Street Journal

Hospitals and health systems, already overwhelmed by treating coronavirus patients, can’t also bear the brunt of vaccinations, Mr. Buxton said. “Health systems like McLaren can’t do this by themselves.”

Pharmacies are well-positioned to play a major role in Covid-19 vaccination efforts, industry executives say, because they are among the most-accessible health-care providers for many Americans, including people 65 and older who often pick up medication from local supermarkets or drugstores. These businesses say they also can draw from their experience in providing shots for flu, shingles and other illnesses.

CVS and Walgreens combined have 19,000 U.S. stores, while Walmart, Rite RAD -10.46% Aid Corp., Kroger and Publix Super Markets Inc., together have another 11,000 locations. Add to that dozens of regional grocers with pharmacy counters.

CVS says it can vaccinate 20 million to 25 million people a month once supplies are available. Walmart said in January that it would be able to vaccinate 10 million to 13 million a month.

President Biden said last Monday that his target of administering 100 million Covid-19 vaccines in his first 100 days in office might rise to 150 million. As of Friday, 27.9 million shots had been administered, out of 49.2 million distributed since mid-December, according to CDC data.

Drugstore chains and retailers with pharmacies say they have the manpower and physical space to handle mass vaccinations and, in some areas, have already stepped in to help local and state officials. Big chains say they have online scheduling tools capable of handling an influx of appointments.

Walgreens has said it plans to hire about 25,000 people across the U.S. to administer the vaccine. It employs 75,000 pharmacists and technicians. CVS, which employs 34,000 pharmacists and 65,000 technicians, declined to say how many workers it is hiring.

The Covid-19 Pandemic

Among the biggest challenges now for retailers is dealing with customers eager to know when it’s their turn.

“We’re doing everything in our power to avoid confusion about how to get vaccinated,” a CVS spokesman said. In addition to long-term care facilities, the drugstore chain is offering shots to select groups in Indiana, Massachusetts, New York and Puerto Rico. People eligible for a vaccine must make an appointment.

“We answer that question dozens, hundreds of times a day,” Charlie Hartig, chief executive of Hartig Drug Stores, a small Midwestern chain, said of the question of vaccine availability. “Education is taking up time.”

Associated Food Stores, a cooperative of more than 400 supermarkets and nearly 40 pharmacies, is working through how its staff will report vaccinations and quickly process claims.

For Associated Food, scheduling has been an area of focus, said Chris Sheard, who oversees pharmacy operations at the company. Its pharmacies have largely operated on a walk-in basis and now are asking customers to schedule appointments for Covid-19 vaccines so it can ensure distancing and cleaning.

President Biden announced plans to boost supplies of Pfizer and Moderna vaccines sent to states for the next three weeks and purchase enough additional doses to vaccinate most of the U.S. population by the end of summer. Photo: Doug Mills/Getty Images

“People would walk up during their lunch break. We can’t do that now,” Mr. Sheard said. The company is trying to get the word out by increasing marketing and social-media efforts, and by providing wait lists where people can sign up.

Others are hunting for space to give out inoculations and partnering with organizations to set up mass vaccination events. Iowa-based grocer Hy-Vee Inc. is working with a local university to set up vaccination stations in a 16,000-square-foot facility, Aaron Wiese, chief health officer at the company, said.

“You’re looking at a significantly greater number when you’re saying 65 and up and people with underlying conditions,” Mr. Wiese said. “Add on other essential workers, you’re going to need more capacity.”

SHARE YOUR THOUGHTS

Will retailers make a difference in the rollout of the vaccine? Why or why not? Join the conversation below.

Hy-Vee plans to use greenhouses, which are temperature controlled and suitable for larger groups. The retailer also started testing so-called waiting pods, where customers can wait after receiving vaccinations, and RVs with exam rooms. Hy-Vee plans to deploy RVs when it goes to manufacturing plants to immunize staff there, Mr. Wiese said.

Mass vaccinations will require a robust online-booking system, said America Davis, communications coordinator for Immunize Nevada, a nonprofit that has set up a website to schedule appointments in the state. It has been scrambling to keep the site working amid crushing demand.

“Health and local officials are literally working around the clock to be sure we’re doing this right,” she said. “I don’t think anyone anticipated just what the uptake of this vaccine would be.”

For More Information

Covid-19 vaccinations are only by appointment and for people who meet local eligibility requirements. CVS, Publix and Kroger have started making limited appointments online; Walgreens, Rite Aid and Walmart aren’t offering online appointments. Check for the latest here:

Write to Sharon Terlep at sharon.terlep@wsj.com and Jaewon Kang at jaewon.kang@wsj.com

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

[mitalipingale]

https://www.pittsburghtribune.org/read-blog/116310_shingles-vaccine-market-share-overview-competitive-analysis-and-forecast-2031.html

The Shingles Vaccine Market in 2023 is US$ 3.99 billion, and is expected to reach US$ 8.63 billion by 2031 at a CAGR of 10.10%.

[freesuitwhispers]

Global   Adult Vaccine Market Segmentation, Demand and Supply 2023

Summary – A new market study, “Global and China Adult Vaccine Market Insights, Forecast to 2026”has been featured on WiseGuyReports.

Adult Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Adult Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Also Read: http://www.marketwatch.com/story/global-adult-vaccine-market-2020-emerging-trends-industry-share-size-demands-growth-opportunities-regional-overview-and-swot-analysis-till-2026-2020-09-30

Segment by Type, the Adult Vaccine market is segmented into

Influenza

Cervical Cancer

Zoster Shingles

Pneumococcal

Meningococcal

MMRV

Hepatitis

DTP

Travel and Miscellaneous

 Segment by Application, the Adult Vaccine market is segmented into

Hospitals

Medical Care Centers

Other

 Regional and Country-level Analysis

The Adult Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Adult Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

 Competitive Landscape and Adult Vaccine Market Share Analysis

Adult Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Adult Vaccine business, the date to enter into the Adult Vaccine market, Adult Vaccine product introduction, recent developments, etc.

The major vendors covered:

GlaxoSmithKline

Sanofi Pasteur

Merck

Novartis

Pfizer

BioCSL (Seqirus)

Protein Sciences

...

FOR MORE DETAILS : https://www.wiseguyreports.com/reports/5865725-global-and-china-adult-vaccine-market-insights-forecast-to-2026

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.                

 Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +162-825-80070 (US)                          

Ph: +44 2035002763 (UK)  

[1-2-3-4-4498-0]

Solar-powered Vaccine Refrigerator Market: A Sustainable Solution for Healthcare

Solar Powered Vaccine refrigerators are designed to store vaccines and other medical products at a stable temperature to ensure they do not degrade. In developing countries with a sunny climate, solar-powered vaccine refrigerators are common. Many vaccines must be stored at low temperatures, some below -15 °C, and others between 2 and 8 °C. If vaccines are not stored correctly, they can lose their effectiveness. The ideal temperature for storing vaccines in the ILR is +2 degrees to + 8 degrees According to the Centre for Disease Control, failure to adhere to recommended specifications for storage and handling of immunobiology’s can reduce or destroy their potency, resulting in inadequate or no immune response in the recipient. Maintenance of vaccine quality is the shared responsibility of all handlers of vaccines from the time a vaccine is manufactured until administration. According to the Immunization Action Coalition, all vaccines should be stored in a refrigerator or freezer that is designed specifically for the storage of biologics or, alternatively, in a separate dedicated unit. A dorm-style combination refrigerator-freezer unit with just one exterior door has been shown to be unacceptable no matter where the vaccine was placed inside the unit. Stand-alone refrigerator or freezer units are best for storage needs. With retail pharmacies now playing a major role in pneumonia, influenza and shingles immunization programs, the value of critical vaccines being stored in pharmacy refrigerators has reached a new high. In fact, it is not uncommon for many pharmacies to now have over $100,000 of product in a single refrigerator during peak seasons.

COVID-19 Impact analysis

The COVID pandemic, and now finally, the vaccination push across the world against the disease has put the spotlight firmly on the role distributed solar products, particularly Solar refrigeration could play

Rockwell Industries Ltd, a commercial cold chain appliances manufacture, Thursday launched its new product called ‘Chillermill’ here. The product is both a freezer and chiller useful to store COVID-19 vaccine at the required temperatures.

The Vaccine Alliance — began buying and installing solar-powered fridges to store vaccines throughout the region. The idea would be a gamechanger for regional and district health workers who often struggle to carry out routine immunizations for children in places with unreliable electricity and cold storage facilities.

Top Impacting Factors

Solar refrigeration was an encouraging development in the early 1980s, providing a substitute for the absorption technology to meet cold chain requirements in remote areas with finite or no electric power. At present, various solar refrigeration models prequalified by the World Health Organization (WHO) are in use. A fresh approach in solar-based refrigeration has emerged, wherein the newly designed solar refrigerator has gotten rid of the need for high priced energy storage batteries employed to power solar refrigerators. This technology called solar direct drive technology uses solar energy to directly freeze water or other cold storage material (for instance, refrigerant) and then, uses the energy stored in the frozen bank to keep the refrigerator cold during nights and rainy days when the upcoming solar energy is not within easy reach.

Market Trends

Solar-powered vaccine refrigerators, also called off-grid photovoltaic (PV) systems, are put to use to maintain a continues temperature suitable for storing vaccines in clinics

In solar-powered vaccine refrigerators, photovoltaic modules transmute the solar energy directly into electricity, which is further employed to power the compressor of the vaccine refrigerator. On the other hand, rechargeable batteries are also used to store electric energy. The charge controller regulates the flow of electricity to protect batteries from over-discharging and overcharging.

Use of solar-based refrigeration for vaccine storage is a major development in the global health care industry. It is useful for remote areas, where electricity is not available in sufficient amounts. The global health care industry has witnessed rapid growth in the recent years. Growing elderly population worldwide, high prevalence of chronic diseases, and advancements in innovative digital technologies are some of the major factors driving the global health care industry.

Electricity rates are inherently turbulent. They fluctuate seasonally, monthly, and annually. Over the last decade, electricity prices had increased enormously and they are poised to increase even more during the forecast period. This, in turn, is projected to rise the demand for use of the solar technology for storage of vaccines in the near future.

There exists high demand for exploration of sustainable and clean sources for energy, as the world tries to limit emissions and targets to reach net zero carbon emissions

Government support in the form of favorable initiatives has driven usage of the solar technology over the last few years. This is estimated to be a major factor driving the global solar-powered vaccine refrigerator market during the forecast period. For instance, the Solar Energy Corporation of India (SECI) has passed a tender, wherein the government would be offering 30% subsidy to the social sector, the residential sector, private and not-for-profit organizations in the field of education, and health care institutions.

Key Benefits of the Report

This study presents the analytical depiction of the Solar-powered vaccine refrigerator industry along with the current trends and future estimations to determine the imminent investment pockets.

The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Solar-powered vaccine refrigerator market share.

The current market is quantitatively analyzed from 2020 to 2030 to highlight the Solar-powered vaccine refrigerator market growth scenario.

Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.

The report provides a detailed Solar-powered vaccine refrigerator market analysis based on competitive intensity and how the competition will take shape in coming years.

Key Market Players : Sundanzer, ACMAS Technologies (P) Ltd KYOCERA Corporation, Renaissance Energy Systems, Sure Chill, Meditech Technologies India Private Limited, Haier, RuthurEnergy Limited, Neumann & Miller, Vestfrost Solutions,, Godrej Appliances,, Dulas Ltd., Qingdao Amed Commercial Refrigeration Equipment Co., Ltd, QINGDAO HERALD CRYOGENIC TECHNOLOGY CO., LTD

[dpimarketreports]

Latest Market Research Reports Available at DPI Research. See the title below:

U.S. Blood Sugar Lancets Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

U.S. Insulin Syringes Market Prospect, Share, Development, Growth and Demand Forecast to 2027

U.S. Non-Invasive Prenatal Testing Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

United States Shingles Vaccine Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

United States Pediatric Vaccines Market 2020 – 2027

United States Influenza Vaccines Market Forecast 2020 – 2027

Global Industrial Robotics Market (By Industry, Application, Region, and Company) and Forecast to 2026

United States Blood Glucose Meter Market Insights Report 2020 – 2027

United States Blood Glucose Test Strips Market Insights Report 2020 – 2027

Cancer Vaccines Market, Pipeline Analysis Report 2020

Worldwide Diabetes Reusable Insulin Delivery Pen Market | Demand Insights Trends Analysis | Opportunities Growth Potential | Forecast to 2026

Worldwide Diabetes Disposable Insulin Delivery Pen Market | Prospect Share Development Growth Demand | Forecast to 2026

Impact of COVID-19 Outbreak | Indian Outbound Travelers Traffic | Market Revenue to the GCC (United Arab Emirates (UAE) Saudi Arabia Oman Qatar Kuwait Bahrain) Countries

Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027

The Philippines: An Amazing Destination for the International and MICE Tourism Market

United States Pneumonia Vaccine Market Size, Market Analysis, Revenue Opportunity, Competitive Analysis and Forecast 2020 – 2026

Global Diabetes Insulin Delivery Pen Market Analysis, Trends, and Forecasts to 2026

India Outbound Tourism Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecasts to 2026

India Outbound MICE Tourism Market: Focus on MICE Trips, Spending, 30 Countries Data, Insights, Analysis, Opportunities, Growth Potential and Forecasts to 2026

China Outbound Tourism Market to GCC Countries and Forecast to 2026

United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026

Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential

China Outbound MICE Travel & Tourism Market: Focus on MICE Trips, Spending, 25 Countries Data, Industry Insights, Analysis and Forecast, 2019 – 2026

Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential

Huge Growth Opportunities in the Vietnam International and MICE Tourism Market and Forecast

India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism to Gulf Cooperation Council (GCC) Countries – Market Trends and Opportunities to 2025

Growth Opportunities in the India Outbound Tourism Market to GCC Countries

Growth Opportunities in the Mauritius International and MICE Tourism Market 2019 – 2025

United States Non-Invasive Prenatal Testing Market 2019 – 2026

United States Carrier Screening Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast to 2026

Saudi Arabia Outbound Travel and Tourism Market Analysis 2013 – 2018 and Forecast 2019 – 2025

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

Macau International & MICE Travelers Market: Current Trends, Opportunity, Growth Potential and Forecast to 2025

Smart Insulin Pen Market Outlook 2026: United States Opportunity and Demand Analysis, Market Forecast 2019 – 2026

Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025

Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 – 2025

United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends, and Forecast to 2026

Blood Glucose Meter Market: United States Industry Analysis,Trends, Market Size and Forecasts up to 2026

Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

Japan Outbound MICE Tourism Market: Traveler Flows, Spending Patterns, Main Destination Markets and Forecast to 2025

China Outbound Tourism Market 2019 – 2025

Sri Lanka MICE Tourism Market: Current Trends, Opportunity, Growth Potential and Forecast to 2025

Global Blockbuster Drugs Market 2015 – 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts

China Proton Therapy Market Size, Status and Forecast to 2025

Global Nanomaterials Market (By Materials Type, End User, Country and Company) and Forecast to 2025

United States Influenza Vaccines Market Report, Analysis and Forecast to 2025

Europe Non–Invasive Prenatal Testing Market Research Report 2018

Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 – 2017) and Future Forecast (2018 – 2025)

Global Neuromodulation Market Research Report 2018

Diabetes Insulin Delivery Pens Market Research Report 2018

China Outbound MICE Tourism Market Report, Analysis and Forecast to 2025

India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism Market Report: Country Outlook, Analysis, Size, Share and Forecast 2018 – 2025

India Inbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism Market Report: Country Outlook, Analysis, Size, Share and Forecast 2018 – 2025

Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025

Indonesia MICE Industry Forecast and Spending to 2025

Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025

Thailand Outbound Tourism Market Research Report 2018

China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology

India Outbound Tourism Market Analysis 2012 – 2017 and Forecast 2018 – 2025

United States and Japan Proton Therapy Market and Forecast

United States Proton Therapy Market and Forecast

United States Non Invasive Prenatal Testing Market and Forecast

Japan Proton Therapy Market Research Report and Forecast

United States MICE Travel and Tourism – Market Trends, Opportunities and Growth Potential

Singapore Meetings, Incentives, Conventions, Exhibitions (MICE) Tourism Market Analysis 2010 – 2017 and Forecast 2018 – 2024

China Outbound Travel and Tourism Market Analysis 2012 – 2017 and Forecast 2018 – 2024

Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation,Competitive Landscape and Future Forecast (2018 – 2025)

Taiwan International Travelers Visitation, Spending Analysis 2012 – 2017 and Future Forecast 2018 – 2024

United States Insulin Delivery Devices Market Outlook: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

United States Pediatric Vaccine Market – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024

Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022

High Intensity Focused Ultrasound System Industry Insights, Trends, Outlook and Competitive Landscape To 2022

Non-Invasive Prenatal Testing (NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017-2024

Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

Mammography Screening Market Outlook 2022: United States Opportunity and Demand Analysis, Market Forecast 2017 – 2022

United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 – 2022

North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022

United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

United States Non-Invasive Prenatal Testing (NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023

United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021

United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

South Korea Medical Tourism Market Insights, Opportunity, Analysis, Market Shares & Forecast 2017 – 2022

High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022

Non-Invasive Prenatal Testing (NIPT) Market Analysis and Forecast

Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development

Influenza Vaccines Market in Top 5 European Countries to 2022 – Market Size, Development and Forecasts

United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast, 2016 to 2022

Seasonal Influenza Vaccine Market Research Report and Forecast

Singapore Meetings, Incentives, Conventions, Exhibitions (MICE) Tourism Market Insights, Opportunity, Analysis, Market Shares & Forecast 2016 – 2021

Neurostimulation Devices Market Insights, Opportunity, Analysis, Market Shares & Forecast 2016 – 2021

Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

Non-Invasive Prenatal Testing Market(NIPT) by Country (Actual and Potential), Test Outlook, Deals Type, Growth, Share, Opportunities and Forecast to 2021

Hong Kong MICE Tourism Market – Trips & Spending to 2021

Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis

Global Neuroendovascular Coil and Non-Coil Devices Market – Growth, Trends and Forecasts (2016 – 2021)

Neurovascular Intervention Market Size, Market Share, Disease Analysis, Major Market Outlook, Product Analysis, Price Trend, Competitive Strategies and Forecast, 2016 to 2021

Global Breast Implants Market Analysis and Forecast 2016 – 2022

Global Hip and Knee Orthopedic Surgical Implants Market Analysis to 2021

Knee Implants Market: Global Industry Analysis and Market Forecast 2016 – 2021

China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021

Global Hip Replacement Implants Market 2016: Market Size, Analysis, Share, Competitive, Growth & Forecast 2021

Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021

High Intensity Focused Ultrasound (HIFU) by Company Profile, Deals Type, Key Trends & Opportunities to 2022

Point of Care Testing – Global Analysis & Market Forecasts

Thailand MICE Industry & Forecast to 2022

United Kingdom Outbound Travel Market – Trips & Spending to 2020

Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022

Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) – Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021

Germany Outbound Tourism Market: Outbound Tourists Visit, Tourists Spending & Forecast to 2020

[nickyshukla1]

Global Shingles Vaccine Market Overview, Size, Share and Trends 2012–2023

Summary - A new market study, titled “Shingles Vaccine Market, 2012 to 2023” has been featured on WiseGuyReports

 Shingles is known as Herpes Zoster which causes a blistering painful rash on the skin which lasts from 2 to 4 weeks. But, for some people, the pain may last for months or years. This pain is called as (PHN) Post Herpetic Neuralgia, which is a common complication of shingles and it’s occurrence increases with age.

 ALSO READ: https://www.marketwatch.com/story/shingles-vaccine-market-global-industry-analysis-size-share-growth-trends-and-forecast-2018-2023-2020-11-06?siteid=bigcharts&dist=bigcharts

 Market Dynamics: Shingles Vaccine Market Increase in the prevalence and incidence of shingles disease around the world and increase in the global ageing population is expected to enhance the growth of shingles vaccine market across the globe. But, lack of awareness, high cost of the vaccination, unfavourable insurance coverage is major restraints of the global shingles vaccine market.

Market Scope: Shingles Vaccine Market The Global Shingles Vaccine Market is classified on the basis of application, type, end user, and geographical regions. Based on the type, global shingles vaccine market is segmented as Live Vaccines Attenuated Vaccines

Based on the application, global shingles vaccine market is segmented as Herpes Zoster Others

Based on the End User, global shingles vaccine market is segmented as Hospitals Clinic Others

Region Overview: Shingles Vaccine Market There are safe and effective vaccines are available for prevention of shingles. In 2006, Merck & Co., Inc. licenced Zostavax for prevention of shingles which is intended for people above 50years of age. In 2016, GSK received FDA approval for its Shingrix, vaccine to prevent shingles which has 90% efficiency in people than zostavax. GSK filed regulatory approvals in Europe, Canada and Japan for Shingrix. Shingles vaccine market is a very high consolidated market with very few market players. It is experiencing a rapid growth due to the new products and it may gain swift in market growth due to the new entrants into the market during the forecast period.

Global Shingles Vaccine Market is segmented into Latin America, North America, Asia Pacific, The Middle East and Africa and Europe. North America is expected to dominate the market followed by Europe, owing to increase in population and rise in prevalence of shingles among population. While in Europe the market is expected to gain demand due to rise in the therapeutic demand from EU. Asia Pacific shingles vaccine market is expected to exhibit a rapid growth in shingles market due to presence of large untapped market areas and unmet needs especially in emerging economies, rise in health concerns, and increase in per capita income. Due to the limited awareness is the main restraint of the shingles vaccine market.

Competition Assessment: Shingles Vaccine Market

Some of the players in global shingles vaccine market

Merck& Co., Inc. (U.S.) GlaxoSmithKline plc (UK) Cipla Inc. (India) Pfizer Inc. (U.S.)

 FOR MORE DETAILS: https://www.wiseguyreports.com/reports/2753940-shingles-vaccine-market-2012-to-2023

 About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.            

 Contact Us:                

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +162-826-80070 (US)                          

Ph: +44 203 500 2763 (UK)